Cyclo (RGDyC)

Cyclo (RGDyC) is a cyclic pentapeptide with anti-angiogenic abilities. Cyclo (RGDyC) can be combined with liposome delivery systems for research on ocular neovascular diseases and cancer[1][2].

Product Specifications

CAS Number

1206475-79-7

UNSPSC

12352209

Target

Biochemical Assay Reagents

Type

Peptides

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/cyclo-rgdyc.html

Purity

98.29

Solubility

DMSO : 83.33 mg/mL (ultrasonic)

Smiles

O=C([C@@H](NC(CNC([C@@H](NC([C@@H](NC1=O)CS)=O)CCCNC(N)=N)=O)=O)CC(O)=O)N[C@@H]1CC2=CC=C(C=C2)O

Molecular Formula

C24H34N8O8S

Molecular Weight

594.64

References & Citations

[1]Lu Y, et al. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting. Nanotechnology. 2013 Apr 5;24 (13) :135101.|[2]Tang M, et al. Photostable and Biocompatible Fluorescent Silicon Nanoparticles-Based Theranostic Probes for Simultaneous Imaging and Treatment of Ocular Neovascularization. Anal Chem. 2018 Jul 3;90 (13) :8188-8195.